Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
2874
-
Total 13F shares, excl. options
-
1.28B
-
Shares change
-
-26M
-
Total reported value, excl. options
-
$145B
-
Value change
-
-$2.87B
-
Put/Call ratio
-
1.03
-
Number of buys
-
1275
-
Number of sells
-
-1253
-
Price
-
$113.66
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q1 2024
3,097 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q1 2024.
ABBOTT LABORATORIES - COM (ABT) has 2,874 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.28B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (165M shares), BlackRock Inc. (133M shares), Capital Research Global Investors (84M shares), STATE STREET CORP (74.7M shares), Capital International Investors (70.2M shares), MORGAN STANLEY (36M shares), GEODE CAPITAL MANAGEMENT, LLC (33.7M shares), WELLINGTON MANAGEMENT GROUP LLP (28.3M shares), NORTHERN TRUST CORP (21M shares), and NORGES BANK (20.2M shares).
This table shows the top 2874 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.